Skip to main content
Viewing from:
Department GEZ-LTA Erasmushogeschool
Intended for healthcare professionals
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Archive
Search for this keyword
Advanced search
Close
More
Main menu
Archive
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are viewing from:
Department GEZ-LTA Erasmushogeschool
You are here
Home
Archive
Volume 83, Issue 3
Obinutuzumab in patients with Sjogren’s disease immunised against rituximab
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Letter
Obinutuzumab in patients with Sjogren’s disease immunised against rituximab
Online download statistics by month:
Online download statistics by month: November 2023 to March 2025
Abstract
Full
Pdf
Nov 2023
2049
133
83
Dec 2023
328
21
5
Jan 2024
382
35
20
Feb 2024
777
71
46
Mar 2024
468
63
40
Apr 2024
220
20
7
May 2024
237
35
26
Jun 2024
352
35
13
Jul 2024
270
22
16
Aug 2024
200
30
21
Sep 2024
259
21
22
Oct 2024
234
19
18
Nov 2024
208
22
9
Dec 2024
186
28
19
Jan 2025
191
30
11
Feb 2025
60
14
13
Mar 2025
6
1
3
Total
6427
600
372
Read the full text or download the PDF:
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF